Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001326110-25-000011
Filing Date
2025-02-12
Accepted
2025-02-12 20:16:36
Documents
1
Period of Report
2025-02-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1739409389.html 4  
1 FORM 4 wk-form4_1739409389.xml 4 7266
  Complete submission text file 0001326110-25-000011.txt   8988
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (844) 696-5235
ImmunityBio, Inc. (Issuer) CIK: 0001326110 (see all company filings)

EIN.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O IMMUNITYBIO, INC. 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address
Adcock Richard (Reporting) CIK: 0001830328 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37507 | Film No.: 25616783